Principal Financial Group’s Theravance Biopharma TBPH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$848K Buy
+52,264
New +$925K ﹤0.01% 1974
2024
Q2
Sell
-14,708
Closed -$132K 2459
2024
Q1
$132K Sell
14,708
-1,682
-10% -$15.6K ﹤0.01% 2244
2023
Q4
$184K Sell
16,390
-2,247
-12% -$22.6K ﹤0.01% 2183
2023
Q3
$161K Buy
18,637
+1,764
+10% +$17K ﹤0.01% 2200
2023
Q2
$175K Sell
16,873
-570
-3% -$6.29K ﹤0.01% 2201
2023
Q1
$189K Sell
17,443
-1,112
-6% -$11.8K ﹤0.01% 2193
2022
Q4
$208K Buy
18,555
+829
+5% +$8.71K ﹤0.01% 2184
2022
Q3
$180K Buy
17,726
+52
+0.3% +$487 ﹤0.01% 2224
2022
Q2
$160K Buy
17,674
+7,149
+68% +$65.9K ﹤0.01% 2332
2022
Q1
$101K Buy
+10,525
New +$103K ﹤0.01% 2425
2021
Q4
Sell
-24,799
Closed -$184K 2628
2021
Q3
$184K Buy
24,799
+9,949
+67% +$111K ﹤0.01% 2445
2021
Q2
$216K Buy
14,850
+740
+5% +$13.9K ﹤0.01% 2454
2021
Q1
$288K Sell
14,110
-9,666
-41% -$184K ﹤0.01% 2288
2020
Q4
$422K Buy
23,776
+12,222
+106% +$219K ﹤0.01% 2153
2020
Q3
$171K Sell
11,554
-572
-5% -$10.7K ﹤0.01% 2226
2020
Q2
$255K Buy
12,126
+3,486
+40% +$89.5K ﹤0.01% 2126
2020
Q1
$200K Buy
8,640
+373
+5% +$9.34K ﹤0.01% 2062
2019
Q4
$214K Buy
+8,267
New +$161K ﹤0.01% 2124
2019
Q1
Sell
-7,907
Closed -$202K 2242
2018
Q4
$202K Sell
7,907
-6,725
-46% -$182K ﹤0.01% 2131
2018
Q3
$478K Buy
+14,632
New +$399K ﹤0.01% 1968
2018
Q2
Sell
-9,674
Closed -$235K 2306
2018
Q1
$235K Buy
9,674
+868
+10% +$23.8K ﹤0.01% 2070
2017
Q4
$246K Buy
8,806
+234
+3% +$6.92K ﹤0.01% 2092
2017
Q3
$294K Sell
8,572
-5,757
-40% -$188K ﹤0.01% 2029
2017
Q2
$571K Buy
14,329
+2,931
+26% +$113K ﹤0.01% 1928
2017
Q1
$420K Buy
+11,398
New +$364K ﹤0.01% 1946

Other funds holding TBPH